Past, present, and future directions for Alzheimer research

Alzheimer Disease and Associated Disorders

Volumn 13, Issue SUPPL. 1, 1999, Pages

  Hurley, Ann C ^a,b,c,e   Wells, Nancy ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY HOSPITAL   (United States)

^e GRECC ENRMVH   (United States)

Author keywords

Alzheimer disease; Grant writing; Research

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID; APOLIPOPROTEIN E; CHOLINERGIC RECEPTOR STIMULATING AGENT; DONEPEZIL; NONSTEROID ANTIINFLAMMATORY AGENT; PRESENILIN 1; PRESENILIN 2; PROTEIN PRECURSOR; SELEGILINE; TACRINE;

ALZHEIMER DISEASE; BUDGET; CAREGIVER; CHROMOSOME 21; CLINICAL TRIAL; DATA BASE; DEMENTIA; DISEASE MARKER; EARLY DIAGNOSIS; ENVIRONMENTAL FACTOR; HEALTH CARE COST; HUMAN; MEDICAL GENETICS; MEDICAL RESEARCH; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN PROCESSING; RISK FACTOR; SHORT SURVEY; SIDE EFFECT;

EID: 0032827610     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199904001-00004     Document Type: Short Survey

References (3)

1. Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA 1989;262:2551-6.
2. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44.
3. Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A. Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psychopharm Bull 1988;24:641-52.